Drug intelligence / Profile preview

salvianolate

Development stage
Phase 4
Lead developer
Green Valley Group
Modality
Small Molecules
Administration
Intravenous
01

Overview

Salvianolate is a water-soluble compound primarily composed of salvia magnesium acetate and related homologues, extracted from the Chinese herb Salvia miltiorrhiza. It is used as an injectable traditional Chinese medicine. Salvianolate exhibits multiple pharmacological activities including antioxidative effects, anti-inflammatory actions, improvement of microcirculation, and protection of vascular endothelium. Its mechanisms involve inhibition of oxidative stress and inflammation (including downregulation of Smad2/3 and TGF-β1 expression), promotion of angiogenesis via stimulation of the VEGF/VEGFR-2 signaling pathway by macrophages, inhibition of platelet aggregation and activation, as well as protection against renal injury. Clinically it is mainly indicated for ischemic cardiocerebral vascular diseases such as coronary heart disease (CHD), unstable angina pectoris, diabetic nephropathy (DN), hypertensive nephropathy (HN), acute cerebral ischemia/stroke, liver damage, diabetes complications, and in-stent restenosis[1][3][4][5][6].

Brand names
Salvianolate Injection
Other names
salvia magnesium acetatesalvia miltiorrhiza polyphenolic acid saltsalvianolate injection
02

Targets

NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)NOX4 (NADPH oxidase 4)VEGFR2 (Vascular endothelial growth factor receptor 2)TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on salvianolate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salvianolate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call